California exempts supplements from food date-labeling rules
CRN says the legislation provides regulatory certainty by clarifying that dietary supplements are excluded from the state’s standardized food date-labeling requirements.
CRN says the legislation provides regulatory certainty by clarifying that dietary supplements are excluded from the state’s standardized food date-labeling requirements.
Circana says advertisers should prepare for earlier shopping and growing use of AI and social platforms for product discovery.
NACDS and pharmacy advocates urge Congress to expand Medicare access to pharmacist services.
The company is expanding its OTC manufacturing plans in North Carolina and developing a new science and innovation center in New Jersey.
Four winning designs will appear on limited-edition CVS brand bandages used for immunizations nationwide beginning in fall 2027.
“The most underused clinician in rural America is ready to do more,” says Emily Aaronson, chief medical officer of Walmart U.S.
The IRB-approved study will enroll 120 women and directly compare two forms of folate used in prenatal nutrition.
The partnership will help Estée Lauder track and optimize how its brands appear on generative AI platforms like ChatGPT and Gemini.
Generics and biosimilars represented 89% of U.S. prescriptions but only 12% of prescription drug spending in 2025, according to AAM.
Researchers found an mRNA flu vaccine produces broader antibodies than conventional ones, offering clues for more lasting influenza protection.
The Orchards Elementary project is part of CVS Health’s multi-year effort to expand access to community recreation through soccer.
Customers can now manage prescriptions, check costs and connect with pharmacists entirely in Spanish.
Endocrinologist Dr. Rocio Salas-Whalen leads a new MasterClass course designed to help patients better understand GLP-1 therapy.
Emarsys finds that fragmented data is preventing many brands from fully deploying AI across customer engagement.
The FTC and 22 states allege Amazon secretly increased advertising prices while misleading brands and sellers about how its ad auctions operated.
NCPA warns that independent pharmacies could be required to provide competitively sensitive acquisition-cost information to vertically integrated PBMs.